世界の末梢インターベンション薬物溶出デバイス市場レポート2020年

QYResearchが発行した調査報告書(QYR20ST07178)
◆英語タイトル:Global Peripheral Intervention Drug-Eluting Devices Sales Market Report 2020
◆商品コード:QYR20ST07178
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年9月(※2024年版があります。お問い合わせください。)
◆ページ数:137
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、北米、ヨーロッパ、日本、アジアなど
◆産業分野:医療機器・消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界の末梢インターベンション薬物溶出デバイス市場について種類別(プレーンオールドバルーン血管形成術(POBA)、経皮経管的血管形成術(PTA))、用途別(薬剤溶出バルーン、薬剤溶出ステント)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・末梢インターベンション薬物溶出デバイス市場の概要
・世界の主要地域別末梢インターベンション薬物溶出デバイス市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の末梢インターベンション薬物溶出デバイス市場規模2015-2026:種類別(プレーンオールドバルーン血管形成術(POBA)、経皮経管的血管形成術(PTA))
・世界の末梢インターベンション薬物溶出デバイス市場規模2015-2026:用途別(薬剤溶出バルーン、薬剤溶出ステント)
・末梢インターベンション薬物溶出デバイスの北米市場規模2015-2020
・末梢インターベンション薬物溶出デバイスのヨーロッパ市場規模2015-2020
・末梢インターベンション薬物溶出デバイスの中国市場規模2015-2020
・末梢インターベンション薬物溶出デバイスの日本市場規模2015-2020
・末梢インターベンション薬物溶出デバイスの東南アジア市場規模2015-2020
・末梢インターベンション薬物溶出デバイスのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・末梢インターベンション薬物溶出デバイスの製造コスト分析
・販売チャネル、流通業者、顧客
・末梢インターベンション薬物溶出デバイスの市場動向・機会・課題
・調査の結論
【レポートの概要】

Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.

Market Analysis and Insights: Global Peripheral Intervention Drug-Eluting Devices Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Peripheral Intervention Drug-Eluting Devices market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Peripheral Intervention Drug-Eluting Devices industry.
Based on our recent survey, we have several different scenarios about the Peripheral Intervention Drug-Eluting Devices YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Peripheral Intervention Drug-Eluting Devices will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global Peripheral Intervention Drug-Eluting Devices Scope and Market Size
The global Peripheral Intervention Drug-Eluting Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peripheral Intervention Drug-Eluting Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Peripheral Intervention Drug-Eluting Devices market is segmented into
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)

Segment by Application, the Peripheral Intervention Drug-Eluting Devices market is segmented into
Drug-Eluting Balloons
Drug-Eluting Stents

The Peripheral Intervention Drug-Eluting Devices market is analysed and market size information is provided by regions (countries). Segment by Application, the Peripheral Intervention Drug-Eluting Devices market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Peripheral Intervention Drug-Eluting Devices Market Share Analysis
Peripheral Intervention Drug-Eluting Devices market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Peripheral Intervention Drug-Eluting Devices business, the date to enter into the Peripheral Intervention Drug-Eluting Devices market, Peripheral Intervention Drug-Eluting Devices product introduction, recent developments, etc.

The major vendors covered:
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. Bard, Inc.
Abbott
The Lubrizol Corporation
Terumo Corporation

【レポートの目次】

1 Peripheral Intervention Drug-Eluting Devices Market Overview
1.1 Peripheral Intervention Drug-Eluting Devices Product Scope
1.2 Peripheral Intervention Drug-Eluting Devices Segment by Type
1.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2020-2026)
1.2.2 Plain Old Balloon Angioplasty (POBA)
1.2.3 Percutaneous Transluminal Angioplasty (PTA)
1.3 Peripheral Intervention Drug-Eluting Devices Segment by Application
1.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Comparison by Application (2020-2026)
1.3.2 Drug-Eluting Balloons
1.3.3 Drug-Eluting Stents
1.4 Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts (2015-2026)
1.4.1 Global Peripheral Intervention Drug-Eluting Devices Sales Growth Rate (2015-2026)
1.4.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2015-2026)
1.4.3 Global Peripheral Intervention Drug-Eluting Devices Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Peripheral Intervention Drug-Eluting Devices Industry Impact
1.5.1 How the Covid-19 is Affecting the Peripheral Intervention Drug-Eluting Devices Industry
1.5.1.1 Peripheral Intervention Drug-Eluting Devices Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Peripheral Intervention Drug-Eluting Devices Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Peripheral Intervention Drug-Eluting Devices Players to Combat Covid-19 Impact

2 Peripheral Intervention Drug-Eluting Devices Estimate and Forecast by Region
2.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Peripheral Intervention Drug-Eluting Devices Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2015-2020)
2.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2015-2020)
2.3 Global Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.2 Europe Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.3 China Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.4 Japan Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.6 India Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
3 Global Peripheral Intervention Drug-Eluting Devices Competition Landscape by Players
3.1 Global Top Peripheral Intervention Drug-Eluting Devices Players by Sales (2015-2020)
3.2 Global Top Peripheral Intervention Drug-Eluting Devices Players by Revenue (2015-2020)
3.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Intervention Drug-Eluting Devices as of 2019)
3.4 Global Peripheral Intervention Drug-Eluting Devices Average Price by Company (2015-2020)
3.5 Manufacturers Peripheral Intervention Drug-Eluting Devices Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Peripheral Intervention Drug-Eluting Devices Players (Opinion Leaders)
4 Global Peripheral Intervention Drug-Eluting Devices Market Size by Type
4.1 Global Peripheral Intervention Drug-Eluting Devices Historic Market Review by Type (2015-2020)
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2015-2020)
4.1.3 Global Peripheral Intervention Drug-Eluting Devices Price by Type (2014-2020)
4.2 Global Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2021-2026)
4.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2021-2026)
4.2.3 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Type (2021-2026)
5 Global Peripheral Intervention Drug-Eluting Devices Market Size by Application
5.1 Global Peripheral Intervention Drug-Eluting Devices Historic Market Review by Application (2015-2020)
5.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
5.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2015-2020)
5.1.3 Global Peripheral Intervention Drug-Eluting Devices Price by Application (2015-2020)
5.2 Global Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2021-2026)
5.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Application (2021-2026)
5.2.3 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Application (2021-2026)

3 North America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
3.2 North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
3.3 North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
3.4 North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)

4 Europe Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
4.2 Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
4.3 Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
4.4 Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)

5 China Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
5.2 China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
5.3 China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
5.4 China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)

6 Japan Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
6.2 Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
6.3 Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
6.4 Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)

7 Southeast Asia Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
7.2 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)

8 India Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
8.2 India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
8.3 India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
8.4 India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Peripheral Intervention Drug-Eluting Devices Business
12.1 Medtronic plc
12.1.1 Medtronic plc Peripheral Intervention Drug-Eluting Devices Corporation Information
12.1.2 Medtronic plc Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Products Offered
12.1.5 Medtronic plc Recent Development
12.2 Boston Scientific Corporation
12.2.1 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Corporation Information
12.2.2 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
12.2.5 Boston Scientific Corporation Recent Development
12.3 Abbott Laboratories
12.3.1 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Corporation Information
12.3.2 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Products Offered
12.3.5 Abbott Laboratories Recent Development
12.4 Cardinal Health
12.4.1 Cardinal Health Peripheral Intervention Drug-Eluting Devices Corporation Information
12.4.2 Cardinal Health Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Products Offered
12.4.5 Cardinal Health Recent Development
12.5 B. Braun Melsungen AG
12.5.1 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Corporation Information
12.5.2 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Products Offered
12.5.5 B. Braun Melsungen AG Recent Development
12.6 Biosensors International Group Ltd.
12.6.1 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Corporation Information
12.6.2 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Products Offered
12.6.5 Biosensors International Group Ltd. Recent Development
12.7 C.R. Bard, Inc.
12.7.1 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Corporation Information
12.7.2 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.7.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Products Offered
12.7.5 C.R. Bard, Inc. Recent Development
12.8 Abbott
12.8.1 Abbott Peripheral Intervention Drug-Eluting Devices Corporation Information
12.8.2 Abbott Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Products Offered
12.8.5 Abbott Recent Development
12.9 The Lubrizol Corporation
12.9.1 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Corporation Information
12.9.2 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
12.9.5 The Lubrizol Corporation Recent Development
12.10 Terumo Corporation
12.10.1 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Corporation Information
12.10.2 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
12.10.5 Terumo Corporation Recent Development

13 Peripheral Intervention Drug-Eluting Devices Manufacturing Cost Analysis
13.1 Peripheral Intervention Drug-Eluting Devices Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
13.4 Peripheral Intervention Drug-Eluting Devices Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Peripheral Intervention Drug-Eluting Devices Distributors List
14.3 Peripheral Intervention Drug-Eluting Devices Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の末梢インターベンション薬物溶出デバイス市場レポート2020年(Global Peripheral Intervention Drug-Eluting Devices Sales Market Report 2020)]についてメールでお問い合わせはこちらでお願いします。